Clinical trial
NovoMix® 30 FlexPen, Post Marketing Surveillance Study
NCT01536613 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- NovoMix® 30 FlexPen, Post Marketing Surveillance Study
- Lead sponsor
- Novo Nordisk A/S
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2004
- Completion date
- February 28, 2007
- Enrollment
- 5,346 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.